Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 1Diabetes Mellitus, Type 2 1Dementia 1Cognitive Dysfunction 1

Interventions

Transcranial Direct Current Stimulation 2Exercise 2mazdutide 1lime 1fasudil 1enzalutamide 1Time 1Tablets 1Standard of Care 1Referral and Consultation 1Ramipril 1Radiosurgery 1Prednisone 1Population Groups 1Palliative Care 1Organization and Administration 1Modafinil 1Methods 1Metformin 1Mental Status and Dementia Tests 1Memantine 1Low-Level Light Therapy 1Hormones 1Health 1Gonadotropin-Releasing Hormone 1Electroencephalography 1Drug Delivery Systems 1Data Collection 1Anesthesia, General 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × mazdutide × 1 year × Clear all
NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 3 Recruiting
420 enrolled
Lymphoid

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡